Wednesday, 13 Dec 2017

PsA/SpA

Datesort ascending Type Title Save
07 Nov 2017 Social RT @Janetbirdope: #GAMECHANGER. Ankylosing spondylitis genetics are biased AS parent is more likely to have AS in sons #acr17 @rheumnow #1
07 Nov 2017 Social RT @uptoTate: Diagnostic, elemental ultrasonographic abnormalities in PsA. Possible diagnostic criteria? #ACR17 @RheumNow #1874 https://t.c…
06 Nov 2017 Social RT @ARD_BMJ: SIJ MRI oedema may be found in many healthy runners @ACRheum #ACR17 https://t.co/l8RtAZvqtJ
06 Nov 2017 Social RT @DrPetryna: #1881 #acr17 Uveitis&scleritis common in AI disease. Lack of consensus on workup guidelines calls for Ophtho/rheum collabora…
06 Nov 2017 Social RT @japaoli19: Significant reduction in immunosuppression load on uveitis pts with long term ADA use. #ACR17 @RheumNow #1115 https://t.co/…
06 Nov 2017 Social RT @uptoTate: What is your 1st line, post DMARD, treatment of advanced active PsA? #ACR17 @RheumNow
06 Nov 2017 Social RT @philipcrobinson: Persistence of MTX at week 24 in PSA is 83%. Not as bad as some people make out #ACR17 @RheumNow Abs 1252 https://t.co…
06 Nov 2017 Social RT @doctorakerkar: Developments to watch for- IL-23 important factor in enthesitis #ACR17 https://t.co/jFrpneTUBL
06 Nov 2017 Social RT @ACRheum: Collaborative ACR/NPF effort yields new clinical guideline for treatment of adult patients w/ active PsA. https://t.co/uw1VFWD…
06 Nov 2017 Social RT @pkiely500: #ACR17 Landewe. Stopping adalimumab in nrAxSpA patients in sustained remission leads to flare after 8-12 weeks in 53% https:…
06 Nov 2017 Social How often do you see &Rx non-radiographic axial SpA pts?
06 Nov 2017 Social Plenary abst#1787 Landawe presents Atlas 5 study, continuation of ADA is assoc w/ signif less flares in nr-AxSpApts… https://t.co/O1xSQ6nafD
06 Nov 2017 Social RT @DrPetryna: Cosentyx significantly improves ACR scores in PsA up to wk156, better in high CRP group #1523 #ACR17 @RheumNow https://t.co/…
06 Nov 2017 Social RT @japaoli19: Osteitis condensans ilii vs AxSpA. OCI-no erosions on CT/female sex/hlab27neg/nmlcrp. #ACR17 @RheumNow #1510 https://t.co/U…
06 Nov 2017 Social RT @japaoli19: Secukinumab meets T2T endpoints in PsA.Early onset did better. Should we measure in clinic? #ACR17 @RheumNow #622 https://t.…
05 Nov 2017 Social RT @doctorakerkar: AxSpA- Does obesity affect response to TNF blockers? #ACR17 #AnkylosingSpondylitis @RheumNow https://t.co/ubmQHTqdVq
05 Nov 2017 Social RT @doctorakerkar: Therapies to look forward to in #AnkylosingSpondylitis #ACR17 https://t.co/h9uZQ08wbD
05 Nov 2017 Social RT @doctorakerkar: The reason why Etoricoxib is preferred NSAID in #AnkylosingSpondylitis #ACR17 @RheumNow https://t.co/gbit47We7n
05 Nov 2017 Social RT @_connectedcare: 12% progression in 2yrs to AS from nrAxSpA #ACR17 @rheumnow https://t.co/QcFR8zzRXF
05 Nov 2017 Social RT @doctorakerkar: High CRP main predictor of progression of nrAxSpA to AS #ACR17 @RheumNow https://t.co/E84Wfj7B1e